Sign up to save your podcasts
Or
Share Life Science Today 001 - Gene Therapy Deaths, FDA Guidelines, and CRISPR Tech
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Life Science Today 001 - Gene Therapy Deaths, FDA Guidelines, and CRISPR Tech
Originally Published as The Niche Podcast
Today on The Niche we will be discussing two deaths in a gene therapy trial, new COVID-19 vaccine guidelines from the FDA, and recent developments in CRISPR-Cas gene editing technologies.
Story References
https://www.liebertpub.com/doi/10.1089/hum.2020.182
https://www.fda.gov/media/139638/download
https://apnews.com/dacdc8bc428dd4df6511bfa259cfec44
https://doi.org/10.1126/science.abb6151
Music by Luke Goodson
https://soundcloud.com/lukegoodson
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
View all episodes
By Noah Goodson, PhD
5
77 ratings
Originally Published as The Niche Podcast
Today on The Niche we will be discussing two deaths in a gene therapy trial, new COVID-19 vaccine guidelines from the FDA, and recent developments in CRISPR-Cas gene editing technologies.
Story References
https://www.liebertpub.com/doi/10.1089/hum.2020.182
https://www.fda.gov/media/139638/download
https://apnews.com/dacdc8bc428dd4df6511bfa259cfec44
https://doi.org/10.1126/science.abb6151
Music by Luke Goodson
https://soundcloud.com/lukegoodson
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.